TechNation: AnyVision raises $ 28 million from Bosch for facial-recognition technology – Business



[ad_1]

AnyVision raises $ 28 million from Bosch for facial-recognition technology

AnyVision, an Israeli startup that has developed face, body and object recognition technology to help companies deploy smart cameras Germany's Bosch. Two unnamed U.S. private equity groups joined the round, which will be used for research and development in Los Angeles, London and Singapore. AnyVision has developed artificial intelligence-based solutions for homeland security and other applications that enable a camera to index and analyze everything it sees. Launched in 2015, the company has 130 employees globally and recently opened its first North American office in New York. CEO Eylon Etshtein told the technology website Crunchbase that AnyVison's technology solves many of the problems surrounding the face of the face of the world. persons of interest. "( TheMarker Staff )
                                                    

Video marketing technology company Eyeview takes in $ 20 million

Eyeview, a U.S. startup founded by Israelis, said last week it had raised $ 20 million in equity financing and debt from a group of current and new investors. The group of mostly Israeli venture capital funds included Qumra, Innovation Endeavors, Nauta Capital, Gemini Israel Ventures and Israel Secondary Fund, Eyeview said. The company's technology enables companies to customize their video ads based on the viewer's data. "In today's ever-changing marketing landscape, it's important to provide marketers with differentiated offerings in order to rise above the crowd," explained CEO Oren Harnevo. Founded in 2007 by Harnevo, Barnea Gal, Tal Riesenfeld and Yaniv Nizan, the company has raised $ 79.7 million to date, according to Crunchbase technology. It has offices in New York, Los Angeles, Detroit and Chicago as well as Lowe's and Walgreens as well as automakers Honda and BMW. and ride-hailing Uber service. ( TheMarker Staff )
                                                    

LR Group to manage $ 130 million Jerusalem Biomedical Fund

LR Group has won a contract from the Jerusalem Development Authority to set up a $ 130 million fund, at least half of which must be invested in local biomedical startups. The authority will invest $ 5 million of its own money and become a limited partner in the fund. It It It It said said said said said said Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y. The fund is a second foray into the biomedical industry for LR, a manager for agriculture, water, energy and telecom projects, after it launched the 50 million shekel ($ 13.7 million) BioJerusalem shared workspace for life sciences startups last month. The authority has been making direct grants to local biomedical startups. "With the help of the new fund and a Chinese partnership, we're significantly leveraging the money we can invest," said Eyal Haimovsky, the CEO's authority. ( Eliran Rubin )
                                                    

[ad_2]
Source link